Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

Reply to this topic

post Posted: Jun 11 2021, 09:04 PM
  Quote Post

Posts: 9,138
Thanks: 2749

Argenica Therapeutics Limited (AGN) was incorporated on 20 November 2019 as a proprietary Australian company to undertake the development and commercialisation of a novel therapeutic known as ARG 007 developed by world-leading researchers at the University of Western Australia (UWA) and the Perron Institute for Neurological and Translational Science (Perron Institute). The therapeutic, which is based on arginine rich peptides, has proven neuroprotective properties and therefore can offer protection to the brain following stroke and other acute central nervous system injuries.

The Company's current business is to develop and commercialise ARG 007. Argenica will initially focus on the use of ARG 007 in the treatment of stroke.

Contact details .....
Principal Activities ... Development and commercialisation of a novel therapeutic

Issue Price ..... $0.20
Issue Type ..... Ordinary Fully Paid Shares
Security code ..... AGN
Capital to be Raised ........ $7,000,000
Expected offer close date ........... 21 May 2021

Underwriter ................ Not underwritten. Alto Capital (Lead Manager)

listed today; opened at 31c. closed the day at 26c

"Every long-term security is nothing more than a claim on some expected future stream of cash that will be delivered into the hands of investors over time. For a given stream of expected future cash payments, the higher the price investors pay today for that stream of cash, the lower the long-term return they will achieve on their investment over time." - Dr John Hussman

"If I had even the slightest grasp upon my own faculties, I would not make essays, I would make decisions." ― Michel de Montaigne

Said 'Thanks' for this post: boylep
post Posted: Aug 13 2008, 03:56 PM
  Quote Post

Posts: 4,290
Thanks: 206

Created by request:



Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.